First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
Laleu
Benoît
B
Genkyotex, S.A., 14 Chemin des Aulx, CH-1228 Plan-Les-Ouates, Switzerland.
Gaggini
Francesca
F
Orchard
Mike
M
Fioraso-Cartier
Laetitia
L
Cagnon
Laurène
L
Houngninou-Molango
Sophie
S
Gradia
Angelo
A
Duboux
Guillaume
G
Merlot
Cédric
C
Heitz
Freddy
F
Szyndralewiez
Cédric
C
Page
Patrick
P